New Alzheimer’s Drug . . . and Dale Bredesen Challenge

Various experts share pros and cons about Lecanemab (starts 1:00) the newly approved drug for Alzheimer’s. Dale Bredesen of Apollo HealthCo (starts 5:30) shares his criticisms of the new Alzheimer’s drug and gives recommendations for better ways to improve cognition. Links to topics mentioned in this show: American Alzheimer’s Association Statement urging Medicare and Medicaid … Continue reading "New Alzheimer’s Drug . . . and Dale Bredesen Challenge"